Janet Schnee

17.7k citations
45 papers · 6.1k indexed · 6 hit papers · h-index 21

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Acute Myocardial Infarction Research
    • Cardiac Arrhythmias and Treatments
    • Heart Failure Treatment and Management

Papers in

    • Venous Thromboembolism Diagnosis and Management 16
    • Atrial Fibrillation Management and Outcomes 19
    • Acute Myocardial Infarction Research 7
    • Heart Failure Treatment and Management 6
    • Antiplatelet Therapy and Cardiovascular Diseases 5

Janet Schnee

43 papers receiving 5.9k citations

Hit Papers

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial 2021 · 226 citations
226200720262013201950010001.5k

Peers

Janet Schnee
Comparison fields: 5 of 98
  • Internal Medicine 4.0k
  • Cardiology and Cardiovascular Medicine 4.8k
  • Hematology 606
  • Endocrinology, Diabetes and Metabolism 666
  • Emergency Medical Services 213
Replace David Baanstra with:
David Baanstra United States
Edelgard Lindhoff‐Last Germany
Ross Baker Australia
Sebastian Schellong Germany
Timothy Brighton Australia
Franco Piovella Italy
Piérre Siè France
Melina Verso Italy
Alejandro Lazo‐Langner Canada
Ulrich Tebbe Germany
Janet Schnee relative to David Baanstra United States David Baanstra's profile →
Citations per field
00.5×1.5×1.9×
David Baanstra · 1×
Citations per year

Countries citing papers authored by Janet Schnee

Since Specialization
Citations

This map shows the geographic impact of Janet Schnee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Schnee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Schnee more than expected).

Fields of papers citing papers by Janet Schnee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Schnee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Schnee. The network helps show where Janet Schnee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Janet Schnee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janet Schnee Line = papers co-authored together Janet Schnee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20237
2
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
Hit paper breakdown →
2021159
3 2020180
4 2019169
5 20173
6 2015101
7 201210
8
Abstract 14413: Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopedic Surgery
20112
9 2011309
10 2010104
11
150 MG DABIGATRAN ETEXILATE ONCE DAILY HAS A GOOD SAFETY PROFILE AND COMPARABLE EFFICACY TO ENOXAPARIN FOR PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE OR HIP REPLACEMENT SURGERY IN PATIENTS OVER 75 YEARS OF AGE
20101
12
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Hit paper breakdown →
20091866
13
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial
Hit paper breakdown →
2007732
14
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Hit paper breakdown →
2007812
15 2004120
16 200191
17 19934
18 199011
19 19891
20 19899

About Janet Schnee

Janet Schnee is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Endocrinology, Diabetes and Metabolism and Physiology, having authored 45 papers that have together received 6.1k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (19 papers), Venous Thromboembolism Diagnosis and Management (16 papers), Diabetes Treatment and Management (12 papers), Cell Adhesion Molecules Research (7 papers), Acute Myocardial Infarction Research (7 papers), Pancreatic function and diabetes (7 papers), Heart Failure Treatment and Management (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). The work is most often cited by research in Internal Medicine (4.0k citations), Cardiology and Cardiovascular Medicine (4.8k citations), Hematology (606 citations), Endocrinology, Diabetes and Metabolism (666 citations) and Emergency Medical Services (213 citations). Janet Schnee has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Stefan Hantel, Samuel Z. Goldhaber, Clive Kearon, Ajay K. Kakkar, Sam Schulman, Sebastian Schellong, David Baanstra, Henry Eriksson, Patrick Mismetti and Bengt I. Eriksson. Their work appears in journals such as Blood, Circulation, Thrombosis and Haemostasis, Thrombosis Research and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026